Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (ανοίγει νέο παράθυρο)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Πηγή‎: Cancer 2013;119(21):3784-7.

Καταχώριση‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (ανοίγει νέο παράθυρο)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (ανοίγει νέο παράθυρο)

Chakrabarti S, Varma S, Singh S, Kumari S

Πηγή‎: Eur J Haematol 1998;60(5):313-4.

Καταχώριση‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (ανοίγει νέο παράθυρο)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (ανοίγει νέο παράθυρο)

Delaney M, Matthews DC, Gernsheimer TB

Πηγή‎: Pediatr Blood Cancer 2017;64(12):e26641.

Καταχώριση‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (ανοίγει νέο παράθυρο)

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. (ανοίγει νέο παράθυρο)

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH, Elmore JM

Πηγή‎: J Urol 2010;184(3):1152-7.

Καταχώριση‎: PubMed 20650477

DOI‎: 10.1016/j.juro.2010.05.020

https://www.ncbi.nlm.nih.gov/pubmed/20650477 (ανοίγει νέο παράθυρο)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (ανοίγει νέο παράθυρο)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Πηγή‎: Leuk Lymphoma 1995;19(1-2):141-4.

Καταχώριση‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (ανοίγει νέο παράθυρο)

Pediatric off-label use of recombinant factor VIIa. (ανοίγει νέο παράθυρο)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Πηγή‎: Pediatrics 2009;123(3):1066-72.

Καταχώριση‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (ανοίγει νέο παράθυρο)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (ανοίγει νέο παράθυρο)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Πηγή‎: Indian J Pediatr 2011;78(8):961-8.

Καταχώριση‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (ανοίγει νέο παράθυρο)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (ανοίγει νέο παράθυρο)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Πηγή‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Καταχώριση‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (ανοίγει νέο παράθυρο)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (ανοίγει νέο παράθυρο)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Πηγή‎: Pediatr Blood Cancer 2016;63(10):1822-8.

Καταχώριση‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (ανοίγει νέο παράθυρο)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (ανοίγει νέο παράθυρο)

Das P, Carcao M, Hitzler J

Πηγή‎: Pediatr Blood Cancer 2006;47(2):206-9.

Καταχώριση‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (ανοίγει νέο παράθυρο)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (ανοίγει νέο παράθυρο)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Πηγή‎: Pediatr Blood Cancer 2008;50(5):1013-7.

Καταχώριση‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (ανοίγει νέο παράθυρο)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (ανοίγει νέο παράθυρο)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Πηγή‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

Καταχώριση‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (ανοίγει νέο παράθυρο)

Off-label use of recombinant factor VIIa in pediatric patients. (ανοίγει νέο παράθυρο)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Πηγή‎: Pediatrics 2012;129(6):e1533-40.

Καταχώριση‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (ανοίγει νέο παράθυρο)

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). (ανοίγει νέο παράθυρο)

Neufeld EJ, Saxena K, Kessler CM, Cooper DL; HTRS Investigators

Πηγή‎: Pediatr Blood Cancer 2013;60(7):1178-83.

Καταχώριση‎: PubMed 23335449

DOI‎: 10.1002/pbc.24472

https://www.ncbi.nlm.nih.gov/pubmed/23335449 (ανοίγει νέο παράθυρο)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (ανοίγει νέο παράθυρο)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Πηγή‎: Med Oncol 2010;27(1):16-9.

Καταχώριση‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (ανοίγει νέο παράθυρο)

Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. (ανοίγει νέο παράθυρο)

Ucar C, Caliskan U

Πηγή‎: Pediatr Hematol Oncol 2006;23(4):339-45.

Καταχώριση‎: PubMed 16621776

DOI‎: 10.1080/08880010600631987

https://www.ncbi.nlm.nih.gov/pubmed/16621776 (ανοίγει νέο παράθυρο)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (ανοίγει νέο παράθυρο)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Πηγή‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Καταχώριση‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (ανοίγει νέο παράθυρο)

The use of DDAVP in children with bleeding disorders. (ανοίγει νέο παράθυρο)

Ben-Ami T, Revel-Vilk S

Πηγή‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

Καταχώριση‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (ανοίγει νέο παράθυρο)

Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). (ανοίγει νέο παράθυρο)

Kobrinsky NL, Tulloch H

Πηγή‎: J Pediatr 1988;112(6):993-6.

Καταχώριση‎: PubMed 3373409

DOI‎: 10.1016/s0022-3476(88)80234-8

https://www.ncbi.nlm.nih.gov/pubmed/3373409 (ανοίγει νέο παράθυρο)

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (ανοίγει νέο παράθυρο)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Πηγή‎: J Pediatr Surg 2013;48(3):689-94.

Καταχώριση‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (ανοίγει νέο παράθυρο)